Landec/$LFCR
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Landec
Lifecore Biomedical Inc is a fully integrated contract development and manufacturing organization (CDMO) that offers differentiated capabilities in the development, filling, and finishing of complex sterile injectable pharmaceutical products in syringes and vials. It manufactures injectable-grade Hyaluronic Acid. Lifecore recognizes revenue in two different product categories, CDMO and fermentation.
Ticker
$LFCR
Sector
Trading on
Industry
Life Sciences Tools & Services
Headquarters
Employees
524
ISIN
US5147661046
Website
Landec Metrics
BasicAdvanced
$255M
-
-$1.49
0.80
-
Price and volume
Market cap
$255M
Beta
0.8
52-week high
$7.78
52-week low
$3.68
Average daily volume
255K
Financial strength
Current ratio
2.706
Quick ratio
1.256
Long term debt to equity
264.507
Total debt to equity
274.83
Interest coverage (TTM)
-0.54%
Management effectiveness
Return on assets (TTM)
-3.10%
Return on equity (TTM)
-83.58%
Valuation
Price to revenue (TTM)
1.753
Price to book
114.28
Price to tangible book (TTM)
-16.07
Price to free cash flow (TTM)
-21.015
Growth
Revenue change (TTM)
7.23%
Earnings per share change (TTM)
124.67%
3-year revenue growth (CAGR)
-1.19%
3-year earnings per share growth (CAGR)
-11.91%
What the Analysts think about Landec
Analyst ratings (Buy, Hold, Sell) for Landec stock.
Landec Financial Performance
Revenues and expenses
Landec Earnings Performance
Company profitability
Landec News
AllArticlesVideos
Lifecore Biomedical, Inc. (LFCR) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation
Accesswire·3 days ago
Lifecore Biomedical, Inc. (LFCR) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation
Accesswire·1 week ago
Lifecore Biomedical Names Mark DaFonseca Chief Commercial Officer
GlobeNewsWire·1 week ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Landec stock?
Landec (LFCR) has a market cap of $255M as of June 06, 2025.
What is the P/E ratio for Landec stock?
The price to earnings (P/E) ratio for Landec (LFCR) stock is 0 as of June 06, 2025.
Does Landec stock pay dividends?
No, Landec (LFCR) stock does not pay dividends to its shareholders as of June 06, 2025.
When is the next Landec dividend payment date?
Landec (LFCR) stock does not pay dividends to its shareholders.
What is the beta indicator for Landec?
Landec (LFCR) has a beta rating of 0.8. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.